期刊文献+

马动脉炎病毒大囊膜糖蛋白真核表达载体的构建与瞬时表达

Construction and transient expression of equine arteritis virus major envelope glycoprotein of eukaryotic expression vector
下载PDF
导出
摘要 将马动脉炎病毒大囊膜糖蛋白基因GL插入真核表达载体pVAX1中构建真核表达载体pVAX1-GL,酶切和测序结果表明构建是正确的,用脂质体转染试剂将其转染BHK-21细胞并通过间接免疫荧光试验检测其在体外的表达情况,结果在转染的细胞表面观察到绿色荧光,证明基因得到了表达,而对照则无绿色荧光,本研究为马动脉炎基因疫苗的研究奠定了基础。 To construct the eukaryotic expression vector of equine arteritis virus major envelope protein gene and observe its expression in vitro, the recombinant expression vector pVAX1-GL was constructed by inserting the GL gene into the eukaryotic expression vector pVAX1. The pVAX1-GL was transfected into BHK-21 cells by lipofectamine and the expressed product was detected by indirect immunofluorescence. Restriction enzymes digestion analysis and sequencing results revealed that the recombinant expression vector pVAX1-GL has been constructed successfully. The indirect immunofluorescence result showed green fluorescence on the membrane of transfected cells. The constructed eukaryotic expression vector of EAV-GL can be expressed in vitro, which lay the foundation for the further study of EAV DNA vaccine.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2006年第2期133-135,共3页 Chinese Journal of Preventive Veterinary Medicine
基金 农业部诊断技术标准和农业部热带亚热带动物病毒学重点实验室开放基金(200205)
关键词 马动脉炎病毒 大囊膜糖蛋白 真核表达载体 equine arteritis virus major envelope glycoprotein eukaryotic expression vector
  • 相关文献

参考文献11

  • 1J萨姆布鲁克,E F弗里奇,T曼尼阿蒂斯.分子克隆实验指南[M].第2版,金冬雁,黎孟枫,译.北京:科学出版社,1997.
  • 2Tobiasch E,Kehm R,Bahr U,et al.Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb/c mice by DNA vaccination; strategy for developing a DNA-vaccine against EAV-infection[J].Virus Genes,2001,22(2):187-199.
  • 3Giese M,Bahr U,Jakob N J,et al.Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus[J].Virus Genes,2002,25(2):159-167.
  • 4Mac Lachlan N J,Balasuriya U B,Hedges J F,et al.Serologic response of horses to the structural proteins of equine arteritis virus[J].J Vet Diagu Invest,1998,10(3):229-236.
  • 5Balasuriya U B,Maclachlan N J,De Vries A A,et al.Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus[J].Virology,1995,10;207(2):518-527.
  • 6Cardwell J M,J L Wood.Equine viral arteritis in the UK[J].Vet Rec,2002,150(26):819-820.
  • 7Echeverria M G.M R Pecoraro.The first isolation of equine arteritis virus in Argentina[J].Rev Sci Tech,2003,22(3):1029-1033.
  • 8Hullinger P J,I A Gardner.Seroprevalence of antibodies against equine arteritis virus in horses residing in the United States and imported horses[J].J Am Vet Med Assoc,2001,219(7):946-949.
  • 9Huovilainen A C,Ek-Kommonen.Equine viral arteritis.Current status in Finland[J].Adv Exp Med Biol,1998,440:649-653.
  • 10Larsen L E,T Storgaard.Phylogenetic characterisation of the G(L) sequences of equine arteritis virus isolated from semen of asymptomatic stallions and fatal cases of equine viral arteritis in Denmark[J].Vet Microbiol,2001,80(4):339-346.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部